Trial Profile
The effect of testosterone replacement in patients with hypogonadotroph hypogonadism due to opioid treatment for non-malignant disease A double-blinded, randomized and placebo-controlled trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jul 2019
Price :
$35
*
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- 21 Jul 2019 Status changed from recruiting to completed.
- 03 May 2016 New trial record